Pancreatitis
Definition
Inflammation of the pancreas causing severe abdominal pain. Monitored as a potential adverse event with GLP-1 receptor agonists. Patients are advised to seek immediate medical attention for severe abdominal pain.
Related Terms in Clinical & Safety
Contraindication
A condition or factor that makes a particular treatment or procedure inadvisable. Absolute contraindications mean the treatment should never be used; relative contraindications mean the benefits may outweigh risks in some cases.
Adverse Event
Any undesirable experience associated with the use of a medical product, whether or not considered related to the product. Serious adverse events include hospitalization, disability, or life-threatening outcomes.
Black Box Warning
The FDA's most serious warning placed on a drug's prescribing information, indicating significant risks of serious or life-threatening adverse effects. GLP-1 agonists carry a black box warning for thyroid C-cell tumors based on rodent studies.
Therapeutic Window
The range of drug dosages between the minimum effective dose and the dose that produces unacceptable toxicity. Narrow therapeutic windows require careful dose monitoring.
Drug Interaction
A change in the effect of a drug when taken with another drug, supplement, or food. Peptide interactions can be pharmacokinetic (affecting absorption/metabolism) or pharmacodynamic (additive/opposing effects).
Washout Period
The time required for a drug to be eliminated from the body after discontinuation, typically 5 half-lives. Important when switching between peptides or before medical procedures.
Anaphylaxis
A severe, potentially life-threatening allergic reaction that can occur within seconds or minutes of exposure. Although rare with peptides, it requires immediate medical attention (epinephrine, emergency services).
Immunogenicity
The ability of a substance to provoke an immune response. Some peptides can trigger anti-drug antibody formation over time, potentially reducing efficacy or causing allergic reactions.